Literature DB >> 24354793

IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.

C Uermösi1, F Zabel, V Manolova, M Bauer, R R Beerli, G Senti, T M Kündig, P Saudan, M F Bachmann.   

Abstract

BACKGROUND: Allergen-specific IgGs are known to inhibit IgE-mediated mast cell degranulation by two mechanisms, allergen-neutralization and engagement of the inhibitory FcγRIIB recruiting the phosphatase SHIP-1. Here we unravel an additional mechanism of IgG-mediated mast cell desensitization in mice: down-regulation of allergen-specific IgE.
METHODS: Mast cells were loaded in vitro and in vivo with monoclonal IgE antibodies specific for Fel d1 and exposed to immune complexes consisting of Fel d1-specific IgG antibodies recognizing different epitopes. Down regulation of IgE was followed by flow cytometry.
RESULTS: Mast cells loaded with 2 different IgE antibodies efficiently internalized the IgE antibodies if exposed to recombinant Feld d1. In contrast, no down-regulation occurred if mast cells were loaded with IgE antibodies exhibiting a single specificity before stimulation with recombinant Fel d1 [corrected]. Interestingly, however, IgEs of a single specificity were rapidly down-regulated in vitro and in vivo in the presence of Fel d1-specific monoclonal IgGs recognizing another epitope on Fel d1. Despite FceRI-internalization, little calcium flux or mast cell degranulation occurred. FcγRIIB played a dual role in the process since it enhanced IgE internalization and prevented cellular activation as documented by the inhibited calcium flux and mast cell degranulation. Similar observations were made in the presence of low concentrations of IgEs recognizing several epitopes on Fel d1.
CONCLUSION: We demonstrate here that Fel d1-specific IgG antibodies interact with FcγRIIB which (i) promotes IgE internalization; and (ii) inhibits mast cell activation. These results broaden our understanding of allergen-specific desensitization and may provide a mechanism for long-term desensitization of mast cells by selective removal of long-lived IgE antibodies on mast cells.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IgE; basic mechanisms; immunotherapy and tolerance induction; mast cells; prevention

Mesh:

Substances:

Year:  2013        PMID: 24354793     DOI: 10.1111/all.12327

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  16 in total

Review 1.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 2.  Allergen Immunotherapy and Atopic Dermatitis: the Good, the Bad, and the Unknown.

Authors:  Patrick Rizk; Mario Rodenas; Anna De Benedetto
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

Review 3.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

4.  Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.

Authors:  Amedee Renand; Luis D Archila; John McGinty; Erik Wambre; David Robinson; Belinda J Hales; Wayne R Thomas; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2015-09-11       Impact factor: 10.793

5.  Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity.

Authors:  Christine Y Y Wai; Nicki Y H Leung; Marco H K Ho; Laurel J Gershwin; Shang An Shu; Patrick S C Leung; Ka Hou Chu
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

6.  Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.

Authors:  Leonard B Weinstock; Jill B Brook; Trisha L Myers; Brent Goodman
Journal:  BMJ Case Rep       Date:  2018-01-11

7.  Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.

Authors:  J M Orengo; A R Radin; V Kamat; A Badithe; L H Ben; B L Bennett; S Zhong; D Birchard; A Limnander; A Rafique; J Bautista; A Kostic; D Newell; X Duan; M C Franklin; W Olson; T Huang; N A Gandhi; L Lipsich; N Stahl; N J Papadopoulos; A J Murphy; G D Yancopoulos
Journal:  Nat Commun       Date:  2018-04-12       Impact factor: 14.919

8.  Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT.

Authors:  Ulrich M Zissler; Constanze A Jakwerth; Ferdinand M Guerth; Lisa Pechtold; Juan Antonio Aguilar-Pimentel; Katharina Dietz; Kathrin Suttner; Guido Piontek; Bernhard Haller; Zuzana Hajdu; Matthias Schiemann; Carsten B Schmidt-Weber; Adam M Chaker
Journal:  EBioMedicine       Date:  2018-10-11       Impact factor: 8.143

Review 9.  Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells.

Authors:  Jiayun Hu; Jiajie Chen; Lanlan Ye; Zelang Cai; Jinlu Sun; Kunmei Ji
Journal:  Clin Transl Allergy       Date:  2018-07-18       Impact factor: 5.871

10.  Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.

Authors:  James A Gregory; Ariel Shepley-McTaggart; Michelle Umpierrez; Barry K Hurlburt; Soheila J Maleki; Hugh A Sampson; Stephen P Mayfield; M Cecilia Berin
Journal:  Plant Biotechnol J       Date:  2016-01-23       Impact factor: 9.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.